Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Tango Therapeutics (TNGX) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Tango Therapeutics (TNGX) over the last 5 years, with Q3 2025 value amounting to 0.3.

  • Tango Therapeutics' Asset Utilization Ratio rose 15108.07% to 0.3 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3, marking a year-over-year increase of 15108.07%. This contributed to the annual value of 0.12 for FY2024, which is 3438.93% up from last year.
  • As of Q3 2025, Tango Therapeutics' Asset Utilization Ratio stood at 0.3, which was up 15108.07% from 0.09 recorded in Q2 2025.
  • Tango Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.3 during Q3 2025, with a 5-year trough of 0.05 in Q2 2022.
  • For the 5-year period, Tango Therapeutics' Asset Utilization Ratio averaged around 0.11, with its median value being 0.09 (2023).
  • In the last 5 years, Tango Therapeutics' Asset Utilization Ratio tumbled by 7909.78% in 2022 and then skyrocketed by 15108.07% in 2025.
  • Quarter analysis of 5 years shows Tango Therapeutics' Asset Utilization Ratio stood at 0.07 in 2021, then decreased by 23.22% to 0.06 in 2022, then soared by 59.29% to 0.09 in 2023, then skyrocketed by 43.04% to 0.13 in 2024, then soared by 136.0% to 0.3 in 2025.
  • Its Asset Utilization Ratio stands at 0.3 for Q3 2025, versus 0.09 for Q2 2025 and 0.14 for Q1 2025.